Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Clin Colorectal Cancer. 2014 Jan 4;13(2):81–86. doi: 10.1016/j.clcc.2013.12.005

Table 2.

Adverse events by highest grade toxicity experienced per patient

Toxicity All Grade Toxicity N (%) Grade 3/4 Toxicity N (%)
Hematologic
Anemia 15 (75%) 2 (10%)
Leukopenia 5 (25%) 0
Neutropenia 5 (25%) 1 (5%)
Thrombocytopenia 14 (70%) 3 (15%)
Non-Hematologic
Dehydration 3 (15%) 2 (10%)
Dizziness 4 (20%) 0
Edema (all sites) 5 (25%) 0
Elevated Alkaline Phosphatase 3 (15%) 0
Elevated AST/ALT 7 (35%) 0
Elevated creatinine 3 (15%) 0
Fatigue 18 (90%) 4 (20%)
GI obstruction 0 2 (10%)
Hyperbilirubinemia 4 (20%) 3 (15%)
Hypertension 4 (20%) 0
Nausea 11 (55%) 2 (10%)
Pain (all sites) 9 (45%) 2 (10%)
Rash/Ulceration 4 (20%) 0
Sensory Neuropathy 6 (30%) 1 (5%)
Vomiting 7 (35%) 2 (10%)